Researchers from QIMR Berghofer have uncovered compelling new evidence that establishes why people with hair loss can be more susceptible to deadly skin cancers.
Oct 3, 2023
0
40
Research by the University of Southampton into the effectiveness of COVID-19 vaccines in people with lymphoma has shown that repeated vaccination increases their ability to prevent infection from the virus, particularly after ...
Jul 3, 2023
0
113
In a study published in Human Genetics, QUT Professor Dale Nyholt and QUT Ph.D. researcher Rafiqul Islam, describe using large-scale genome-wide associations studies (GWAS) summary statistics to analyze hundreds of thousands ...
Feb 23, 2023
0
88
Once adults reach age 65, the threshold age for the onset of Alzheimer's disease, the extent of their genetic risk may outweigh age as a predictor of whether they will develop the fatal brain disorder, a new study suggests.
Mar 30, 2023
0
91
A medical researcher at Tel Aviv University, working with a group of computer scientists at the Weizmann Institute of Science, both in Israel, has found that fasting glucose levels in nondiabetic people vary more than previously ...
It's known by many names: semaglutide, the skinny pen, Hollywood's worst-kept secret. The injectable drug Ozempic has exploded in popularity in the 12 months, appearing frequently in news headlines and the TikTok feed.
Feb 13, 2023
0
40
One University of Kentucky (UK) researcher has helped solve a 60-year-old mystery about one of the body's most vital organs: The heart.
Nov 14, 2023
0
101
Nearly two in five U.S. adults have high cholesterol, according to the Centers for Disease Control and Prevention (CDC). Untreated, high cholesterol can lead to heart disease and stroke, which are two of the top causes of ...
Dec 18, 2023
1
160
COVID-19 infections can cause potentially life-threatening heart issues. Studies suggest that people with COVID-19 are 55% more likely to suffer a major adverse cardiovascular event, including heart attack, stroke and death, ...
Feb 18, 2023
2
49
A randomized controlled trial in Hong Kong finds that the synbiotic drug SIM01 relieves multiple symptoms of long COVID, or post-acute COVID-19 syndrome (PACS).
Dec 29, 2023
0
140
